Medicare is urged to consider Amgen patent maneuvers when negotiating the price for a drug; Eli Lilly to pay $200 million for Beam’s share of drugs from gene-editing firm Verve
Taking stock of the drug industry, from the lab to the medicine chest October 31, 2023 Check out STAT+ Sponsored By By Ed Silverman Pharma...Read More